Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Eph/Ephrin family in cancer metastasis: communication at the service of invasion
Mustapha Kandouz
Cancer and Metastasis Reviews (2012) Vol. 31, Iss. 1-2, pp. 353-373
Closed Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Therapeutic advances of targeting receptor tyrosine kinases in cancer
Ciprian Tomuleasa, Adrian Bogdan Țigu, Raluca Munteanu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Eph Receptors in Cancer
Sakshi Arora, Andrew M. Scott, Peter W. Janes
Biomedicines (2023) Vol. 11, Iss. 2, pp. 315-315
Open Access | Times Cited: 23
Gene Expression Correlations in Human Cancer Cell Lines Define Molecular Interaction Networks for Epithelial Phenotype
Kurt W. Kohn, Barry M. Zeeberg, William C. Reinhold, et al.
PLoS ONE (2014) Vol. 9, Iss. 6, pp. e99269-e99269
Open Access | Times Cited: 91
Targeting Eph/ephrin system in cancer therapy
Alessio Lodola, Carmine Giorgio, Matteo Incerti, et al.
European Journal of Medicinal Chemistry (2017) Vol. 142, pp. 152-162
Closed Access | Times Cited: 77
Eph receptor and ephrin function in breast, gut, and skin epithelia
Bethany E. Perez White, Spiro Getsios
Cell Adhesion & Migration (2014) Vol. 8, Iss. 4, pp. 327-338
Open Access | Times Cited: 70
Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT
Yao Zhao, Chenchen Cai, Miaomiao Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2021) Vol. 147, Iss. 7, pp. 2013-2023
Open Access | Times Cited: 41
New insights into the function and pathophysiology of the ectodomain sheddase A Disintegrin And Metalloproteinase 10 (ADAM10)
David P. Rosenbaum, Paul Säftig
FEBS Journal (2023) Vol. 291, Iss. 13, pp. 2733-2766
Open Access | Times Cited: 22
Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients’ survival
Constantinos Giaginis, Nikolaos Tsoukalas, Evangelos Bournakis, et al.
BMC Clinical Pathology (2014) Vol. 14, Iss. 1
Open Access | Times Cited: 63
Ephs in cancer progression: complexity and context-dependent nature in signaling, angiogenesis and immunity
Xiaoting Guo, Yanyi Yang, Jingqun Tang, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Dancing with the dead: Eph receptors and their kinase-null partnersThis paper is one of a selection of papers published in a Special Issue entitled CSBMCB 53rd Annual Meeting — Membrane Proteins in Health and Disease, and has undergone the Journal’s usual peer review process.
Luke Truitt, Andrew Freywald
Biochemistry and Cell Biology (2011) Vol. 89, Iss. 2, pp. 115-129
Closed Access | Times Cited: 54
Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells
Sahiti Chukkapalli, Mohamed Amessou, Ashok K. Dilly, et al.
Experimental Cell Research (2013) Vol. 320, Iss. 2, pp. 233-246
Closed Access | Times Cited: 49
Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma
Terra Vleeshouwer-Neumann, Michael Phelps, Theo K. Bammler, et al.
PLoS ONE (2015) Vol. 10, Iss. 12, pp. e0144320-e0144320
Open Access | Times Cited: 47
The epithelial-mesenchymal interactions: insights into physiological and pathological aspects of oral tissues
Arvind Babu Rajendra Santosh, Thaon Jones
Oncology Reviews (2014)
Open Access | Times Cited: 45
A Cell-Surface Membrane Protein Signature for Glioblastoma
Dhimankrishna Ghosh, Cory C. Funk, Juan Caballero-Pérez, et al.
Cell Systems (2017) Vol. 4, Iss. 5, pp. 516-529.e7
Open Access | Times Cited: 44
EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression
Shibao Li, Yingyu Ma, Chongwei Xie, et al.
Oncotarget (2015) Vol. 6, Iss. 26, pp. 22587-22597
Open Access | Times Cited: 43
Promiscuous and specific recognition among ephrins and Eph receptors
Dandan Dai, Qiang Huang, Ruth Nussinov, et al.
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2014) Vol. 1844, Iss. 10, pp. 1729-1740
Open Access | Times Cited: 43
A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy
Shintaro Taki, Haruhiko Kamada, Masaki Inoue, et al.
PLoS ONE (2015) Vol. 10, Iss. 12, pp. e0144712-e0144712
Open Access | Times Cited: 41
Diversity of Intercellular Communication Modes: A Cancer Biology Perspective
Thanzeela Ebrahim, Abdul Shukkur Ebrahim, Mustapha Kandouz
Cells (2024) Vol. 13, Iss. 6, pp. 495-495
Open Access | Times Cited: 4
Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma
Ben Davidson, Vera M. Abeler, Ellen Hellesylt, et al.
Gynecologic Oncology (2012) Vol. 128, Iss. 2, pp. 349-355
Open Access | Times Cited: 41
Therapeutic perspectives of Eph–ephrin system modulation
Massimiliano Tognolini, Iftiin Hassan‐Mohamed, Carmine Giorgio, et al.
Drug Discovery Today (2013) Vol. 19, Iss. 5, pp. 661-669
Closed Access | Times Cited: 41
Eph receptors and their ligands: Promising molecular biomarkers and therapeutic targets in prostate cancer
Jessica Lisle, Inga Mertens‐Walker, Raphael Rutkowski, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2013) Vol. 1835, Iss. 2, pp. 243-257
Closed Access | Times Cited: 39
Eph receptors: New players in Alzheimer's disease pathogenesis
Moustapha Cissé, Frédéric Checler
Neurobiology of Disease (2014) Vol. 73, pp. 137-149
Closed Access | Times Cited: 37
EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10‐ablation
Chaoqun You, Kai Zhao, Philipp Dammann, et al.
Journal of Cellular and Molecular Medicine (2017) Vol. 21, Iss. 9, pp. 1848-1858
Open Access | Times Cited: 36
Development of Specific, Irreversible Inhibitors for a Receptor Tyrosine Kinase EphB3
Alvin Kung, Ying‐Chu Chen, Marianne Schimpl, et al.
Journal of the American Chemical Society (2016) Vol. 138, Iss. 33, pp. 10554-10560
Open Access | Times Cited: 34
Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine
Bridget A. Quinn, Si Wang, Elisa Barile, et al.
Oncotarget (2016) Vol. 7, Iss. 13, pp. 17103-17110
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top